Studies of estrogen metabolism, formation of DNA adducts, carcinogenicity, cell transformation and mutagenicity have led to the hypothesis that reaction of certain estrogen metabolites, predominantly catechol estrogen-3,4-quinones, with DNA can generate the critical mutations initiating breast, prostate and other cancers. The endogenous estrogens estrone (E 1 ) and estradiol (E 2 ) are oxidized to catechol estrogens (CE), 2-and 4-hydroxylated estrogens, which can be further oxidized to CE quinones. To determine possible DNA adducts of E 1 (E 2 )-3,4-quinones [E 1 (E 2 )-3,4-Q], we reported previously that the reaction of E 1 (E 2 )-3,4-Q with dG produces the depurinating adduct 4-hydroxyE 1 (E 2 )-1-N7Gua [4-OHE 1 (E 2 )-1-N7Gua] by 1,4-Michael addition (Stack et al., Chem. Res. Toxicol., 1996, 9, 851). We report here that reaction of E 1 (E 2 )-3,4-Q with Ade results in the formation of 4-OHE 1 (E 2 )-1-N3Ade by 1,4-Michael addition. The N7Gua and N3Ade depurinating adducts formed both in vitro and in rat mammary gland in vivo were analyzed by HPLC with electrochemical detection and, for some samples, by LC/MS/MS. When E 2 -3,4-Q was reacted with DNA in vitro, the depurinating adducts 4-OHE 1 (E 2 )-1-N3Ade and 4-OHE 1 (E 2 )-1-N7Gua, which are rapidly lost from DNA by cleavage of the glycosyl bond, were formed (499% of the total adducts), as well as traces of stable adducts, which remain in DNA unless removed by repair. Similar results were obtained when 4-OHE 2 was oxidized by horseradish peroxidase, lactoperoxidase, tyrosinase or phenobarbital-induced rat liver microsomes in the presence of DNA. When 4-OHE 2 or E 2 -3,4-Q was injected into the mammary glands of female ACI rats in vivo and the mammary tissue was excised 1 h later, the depurinating adducts 4-OHE 2 -1-N3Ade and 4-OHE 2 -1-N7Gua constituted 499% of the total adducts formed. In addition, 4-OHE 2 conjugates formed by reaction of E 2 -3,4-Q with glutathione were also detected. These results demonstrate that the 4-CE are metabolized to CE-3,4-Q, which react with DNA to form primarily depurinating adducts. These adducts can generate the critical mutations that initiate cancer (Chakravarti et al
Introduction
Experiments on estrogen metabolism (1±7), formation of DNA adducts (8±12), carcinogenicity (13±16), cell transformation (17±19) and mutagenicity (20±22) have led to the hypothesis that certain estrogen metabolites, predominantly catechol estrogen-3,4-quinones, react with DNA and can generate the critical mutations initiating breast, prostate and other cancers (12) .
Among the major metabolites of the estrogens are the catechol estrogens (CE), 2-and 4-hydroxylated estrogens. In general, the major metabolites are the 2-CE, whereas the 4-CE are the minor ones. The pathway to give 4-CE is the one that leads to the endogenous carcinogenic catechol estrogen-3,4-quinones ( Figure 1 ). 4-Hydroxyestrone (4-OHE 1 ) and 4-hydroxyestradiol (4-OHE 2 ) are formed from estrone (E 1 ) and estradiol (E 2 ), which are biochemically interconvertible by the enzyme 17b-estradiol dehydrogenase ( Figure 1 ). The most common pathway of conjugation of 4-OHE 1 (E 2 ) in extrahepatic tissues occurs by O-methylation, which is catalyzed by the ubiquitous catechol-O-methyltransferase (COMT) (24) . This inactivating pathway is in competition with the activation of CE to semiquinones (not shown in Figure 1 ) and quinones ( Figure 1) ; these oxidations are catalyzed by peroxidases and cytochrome P450. The quinones can be inactivated by formation of glutathione (GSH) conjugates and/or by reduction to CE by quinone reductase. If, however, these two processes are insufficient, the CE-3,4-quinones can react with DNA to form the depurinating adducts 4-OHE 1 (E 2 )-1-N3Ade and 4-OHE 1 (E 2 )-1-N7Gua (499.6%), which are rapidly lost from DNA by cleavage of the glycosyl bond, and traces of stable adducts, which remain in DNA unless removed by repair (12) .
To determine the possible DNA adducts of E 1 (E 2 )-3,4-Q, standard adducts were synthesized by reaction of these quinones with dG, dA and the nucleobase Ade (9, 25) . Reaction of E 1 (E 2 )-3,4-Q with dG produced the depurinating adduct 4-OHE 1 (E 2 )-1-N7Gua by 1,4-Michael addition ( Figure 2 ) (25) . Reaction of E 1 (E 2 )-3,4-Q with dA did not afford any adduct (25) ; however, reaction of E 1 (E 2 )-3,4-Q with Ade resulted in the formation of 4-OHE 1 (E 2 )-1-N3Ade by 1,4-Michael addition (9) . This adduct was obtained with Ade and not with dA because the adjacent deoxyribose moiety at N-9 in dA hinders the approach of the electrophile E 1 (E 2 )-3,4-Q to the N-3 of dA. This is also true for polycyclic aromatic hydrocarbons (26±29). In reactions with DNA, however, hydrocarbon-N3Ade (30, 31) and 4-OHE 1 (E 2 )-1-N3Ade (9) adducts are formed and are rapidly lost from DNA by depurination.
This article reports the synthesis and structure determination of 4-OHE 1 (E 2 )-1-N3Ade adducts, and the formation of 4-OHE 2 -1-N3Ade and 4-OHE 2 -1-N7Gua adducts in DNA in vitro and in the mammary gland of female ACI rats in vivo.
Materials and methods
Materials 2-OHE 1 , 2-OHE 2 , 4-OHE 1 , 4-OHE 2 , E 1 -3,4-Q and E 2 -3,4-Q were prepared as described previously (32±34). The 4-OHE 1 (E 2 )-2-glutathione (SG), 4-OHE 1 (E 2 )-2-cysteine (Cys) and 4-OHE 1 (E 2 )-2-N-acetylcysteine (NAcCys) were synthesized according to the procedure of Cao et al. (35) . 4-OHE 2 -1-N7Gua was synthesized according to Stack et al. (25) . 16a-OHE 1 and methoxy derivatives of CE were purchased from Steraloids (Newport, RI). Ade was purchased from Aldrich (Milwaukee, WI). Estriol (16a-OHE 2 ), ascorbic acid, horseradish peroxidase (Type VI), lactoperoxidase, tyrosinase, H 2 O 2 and NADPH were purchased from Sigma Chemicals (St Louis, MO). Liver microsomes from phenobarbital-induced female Sprague±Dawley rats (Harlan, Indianapolis, IN) were prepared by a previously published method (36) . Female ACI rats were obtained from Harlan Sprague±Dawley (Indianapolis, IN). Bond Elut Certify II SPE cartridges (200 mg) were purchased from Varian (Palo Alto, CA). Product-ion mass spectra were obtained with an LCQ classic ion-trap mass spectrometer (Finnigan, San Jose, CA) equipped with an electrosprayionization (ESI) source. 4-OHE 2 -1-N3Ade and 4-OHE 1 -1-N3Ade were dissolved in separate experiments in a solution of acetonitrile/H 2 O (1:1) to give a final concentration of 5 mM. The sample solutions were injected directly at 5 ml/min to the mass spectrometer with a syringe pump. The spray voltage was 5.0 kV, and the capillary temperature was 200 C. The spray was stabilized by 5 Â 10 5 Pa coaxial flow of nitrogen. The collision energy was set to 30% of the maximum (~5 eV) available on the instrument. Product-ion spectra were also acquired with a quadrupole time-of-flight mass spectrometer, as described below. The collision-cell offset was set at 270 V.
Exact mass measurements were conducted with a Micromass Q-TOF Ultima GLOBAL equipped with a Z-spray ESI source. 4-OHE 2 -1-N3Ade and 4-OHE 1 -1-N3Ade were diluted to 5 mM in acetonitrile/H 2 O (1:1) and infused directly with the mass standard sodium trifluoroacetate as the internal mass calibrant (37) . The electrospray needle was 3.5 kV, and the cone voltage was 10 V. The temperature of the source block desolvation region was 120 C. The MCP detector was set to 2200 V. The mass resolving power was 10 000 full width at half maximum.
Synthesis of 4-OHE 2 -1-N3Ade and 4-OHE 1 -1-N3Ade To a suspension of activated MnO 2 (119 mg, 1.37 mmol) in 5 ml of dimethylformamide (DMF) at 0 C was added 4-OHE 2 (60 mg, 0.21 mmol). After 10 min of stirring at 0 C, the resulting E 2 -3,4-Q in DMF was filtered, directly added dropwise into a stirred solution of Ade (170 mg, 1.26 mmol) dissolved in 5 ml of acetic acid and water (1:1, v/v), and allowed to react for~5 h with stirring at room temperature. The solution was then filtered and analyzed by HPLC.
Analytical HPLC was conducted on a Waters (Milford, MA) 2690 Separations Module equipped with a Waters 996 photodiode array detector; the eluent was monitored at 270 nm. A YMC ODS-AQ 5 mm 120-A Ê column (6 Â 250 mm, Morris Plains, NJ) was eluted with 70% water (containing 0.4% acetic acid)/ 30% methanol for 10 min, then a 35-min linear gradient to 65% methanol, followed by a 15-min linear gradient to 100% methanol at a flow rate of 1 ml/min. To purify the synthesized adduct, preparative HPLC was conducted on a YMC ODS-AQ 5 mm 120-A Ê column (20 Â 250 mm) eluted with 50% methanol in water (containing 0.4% acetic acid) for 45 min, followed by a 5-min linear gradient to 75% methanol and a 10-min linear gradient to 100% methanol at a flow rate of 8 ml/min. The yield of 4-OHE 2 -1-N3Ade was 57%.
4-OHE 1 -1-N3Ade was synthesized by following the same procedure, and the yield was 44%. Covalent binding of E 2 -3,4-Q and enzymatically activated 4-OHE 2 to DNA in vitro E 2 -3,4-Q or enzymatically activated 4-OHE 2 was bound to DNA according to previously published procedures (8) . E 2 -3,4-Q (3.5 mmol/50 ml DMSO) was incubated with 10 ml of 3 mM calf thymus DNA in 0.067 M sodium-potassium phosphate (pH 7.0) for 2 h at 37 C. 4-OHE 2 was bound to DNA in 15-ml reactions catalyzed by horseradish peroxidase, lactoperoxidase, tyrosinase or phenobarbital-induced rat liver microsomes during 2 h of incubation at 37 C. For peroxidase-catalyzed reactions, the mixtures contained 3 mM calf thymus DNA in 0.067 M sodium-potassium phosphate (pH 7.0), 0.5 mM H 2 O 2 , 4-OHE 2 (3.5 mmol/50 ml DMSO) and 100 mg/ml horseradish peroxidase (31 U, type VI) or 100 mg/ml lactoperoxidase (9 U). The tyrosinase reaction mixtures contained 3 mM DNA in 0.067 M sodium-potassium phosphate (pH 7.0), 100 mg/ml tyrosinase (480 U, from mushrooms) and were incubated in uncapped tubes. For the microsome-catalyzed reactions, 15-ml mixtures contained 3 mM DNA in 150 mM Tris±HCl (pH 7.5), 150 mM KCl, 5 mM MgCl 2 , 4-OHE 2 (3.5 mmol/50 ml DMSO), 1 mg/ml microsomal protein and 1 mM cumene hydroperoxide. Control reactions were conducted with either no enzyme or no cofactor. At the end of the incubation, a 1-ml aliquot was removed for analysis of stable adducts after purification of DNA. Two volumes of ethanol was added to the remainder of the mixture to precipitate DNA, and the supernatant was used to analyze depurinating adducts.
4-OHE
Analysis of depurinating adducts from in vitro incubations by HPLC Supernatants from the in vitro reactions were evaporated to dryness under vacuum. The residues were dissolved in 1 ml of DMSO/methanol (1:1) and analyzed first by preparative HPLC on a Waters 2690 Separations Module equipped with a YMC ODS-AQ 5 mm 120-A Ê column (10 Â 250 mm), which was eluted with 30% methanol in water for 20 min, followed by a 20-min linear gradient to 52% methanol in water, 10 min at 52% methanol and then a10-min linear gradient to 100% methanol, which was continued for 10 min at a flow rate of 4 ml/min. An initial run was conducted with the standard adducts to establish the retention times of 4-OHE 2 -1-N3Ade (~36 min) and 4-OHE 2 -1-N7Gua (~41 min). Then the DMSO/methanol extracts were separated and fractions were collected at the retention times of the standard adducts. The solvent in the collected fractions was removed under vacuum, and the residues were redissolved in 0.5 ml of methanol. A 50-ml aliquot of the fraction was then analyzed by HPLC on an ESA CoulChem electrochemical detector (Chelmsford, MA) equipped with a YMC ODS-AQ 5 mm, 120-A Ê column (4.6 Â 250 mm), which was eluted with 33% acetonitrile in 50 mM ammonium phosphate, pH 3.0, at a flow rate of 1 ml/min. The remainder of the fraction was analyzed by liquid chromatography/MS (LC/MS).
Analysis of stable adducts by
32 P-postlabeling 32 P-postlabeling analysis of stable DNA adducts was carried out with 8 mg DNA on 10 Â 13 cm polyethylenimine-cellulose plates. The experimental procedures for the enzymatic hydrolysis of DNA (except that the T4 kinase reaction was carried out at pH 8.2), and the D1, D2 and D4 chromatographic steps were as described previously (32), but the D3 direction of chromatographic separation was modified. After the D2 chromatographic step, the adducts were located by autoradiography and the chromatographic plate was cut into two equal halves. A paper wick was attached to the lower half, which was developed overnight (~15 h) with 0.7 M sodium acetate and 7 M urea, pH 6.4. The upper half of the plate was developed with 0.35 M sodium phosphate, 3.5 M urea, pH 6.4. After D4 development, the adduct spots on both halves were visualized by autoradiography and quantified by liquid scintillation counting of excised spots.
Treatment of rats
Groups of five female ACI rats (10 weeks old) were lightly anesthetized with ether, and the mammary region was shaved. They were then treated with either 4-OHE 2 or E 2 -3,4-Q by intramammillary injection (with a 27-gauge needle) under the nipple region of the fourth and fifth mammary glands on both the right and left sides, at a dose of 200 nmol/gland in 20 ml of DMSO. Animals used as control were treated with 20 ml of DMSO. After 1 h, the animals were killed and the mammary gland areas were excised. Mammary tissue was minced, ground in liquid nitrogen and split into two samples weighing~1 and 8 g each. The smaller sample was used for isolation of DNA and analysis of stable adducts by the 32 P-postlabeling method, whereas the larger sample was used for analysis of metabolites and conjugates.
Extraction of estrogen derivatives
Ground mammary tissue was divided into three portions of~2.5 g each, and each was extracted with 6 ml of hexane to remove lipids. After centrifugation and evaporation of hexane, the pellet was suspended in 3 ml of 50 mM ammonium acetate, pH 5.0. One-third of the tissue was analyzed in each run. Methanol was added to all fractions such that the final concentration of methanol was 60%. The supernatant was diluted to an approximate final concentration of 25% methanol with 30 mM ammonium acetate buffer, pH 4.4, containing 2 mg/ml ascorbic acid, and the resulting solution was applied to a Certify II Sep-Pak cartridge. The cartridge was first eluted with 3 ml of the buffer, followed by elution with 2 ml each of 20 and 40% and 3 ml of 70% methanol in buffer. The 70% fraction was analyzed by HPLC equipped with an ESA CoulArray electrochemical detector and by LC/MS.
Extraction of depurinating DNA adducts from mammary tissue Approximately 1 g of ground mammary tissue was suspended in 3 ml of 1% acetic acid and incubated 5 h at room temperature. Afterwards, the depurinating DNA adducts, 4-OHE 1 (E 2 )-1-N7Gua and 4-OHE 1 (E 2 )-1-N3Ade, were Soxhlet extracted with methanol/chloroform (1:1) for 24 h. The extracts were DNA adducts of E 2 -3,4-Q formed in vitro and in vivo evaporated and the residues were dissolved in DMSO/methanol (1:1). The depurinating DNA adducts in the extracts were initially purified by preparative HPLC by using a methanol/0.4% acetic acid gradient. The gradient started with 30% methanol for 1 min at a flow rate of 1 ml/min, followed by a flow rate of 4 ml/min for 10 min, then a 35-min linear gradient to 65% methanol, and a 5-min linear gradient to 100% methanol. Collected fractions of adducts were analyzed by HPLC equipped with an ESA CoulChem II electrochemical detector, as well as by MS.
HPLC analysis of CE derivatives in mammary tissue
Based on a previously described procedure (11), the compounds were separated using a 50-min linear gradient starting with 100% acetonitrile/ methanol/0.1 M ammonium acetate, pH 4.4, 15:5:80±90% acetonitrile/methanol/0.1 M ammonium acetate, pH 4.4, 50:20:30 at a flow rate of 1 ml/min. The serial array of 12 coulometric electrodes was set at potentials between 0 and 590 mV (0, 40, 80, 130, 180, 230, 280, 340 , 400, 470, 530 and 590 mV, respectively). The system was controlled and data acquired and processed using CoulArray software. Peaks were identified by both retention times and by peak height ratios between the dominant peak and the peaks in the two adjacent channels. The analytes were quantified by comparison of peak heights with known amounts of standards.
LC-MS/MS analysis of estrogen metabolites, conjugates and depurinating adducts
Fractions from preparative HPLC were analyzed by LC-MS to confirm the identification of the depurinating DNA adducts, whereas fractions obtained by solid phase extraction were analyzed by LC-MS in an effort to confirm the results of the coulometric detection of the metabolites and thioether conjugates. For the in vitro experiments, all LC-MS and LC-MS/MS data were collected using a PE Sciex API 365 (PE Sciex, Foster City, CA) triple quadrupole mass spectrometer equipped with a Sciex turboionspray inlet. The mass spectrometer was operated in the positive ion mode, and the ionspray needle, orifice and ring electrodes were maintained at 5000, 55 and 300 V, respectively. Nitrogen was used separately as collision, turboionspray, nebulizer and curtain gas. The turboionspray gas was heated to 350 C to assist in desolvation. For all Q1 scans, the mass spectrometer was scanned from m/z 50 to 750 in 0.25 m/z steps with 0.9 ms dwell time. For the MS/MS experiments, the collision energy was optimized between 35±50 eV for each set of experiments.
All LC separations were performed by using a 100 Â 2 mm Â 5 mm Keystone Betasil C-18 column and Shimadzu LC-10-AS pumps, an SCL-10A controller and an SIL-10A autoinjector. The mobile phase, which consisted of 25 mM ammonium acetate at pH 4 (with acetic acid) (Solvent A) and methanol (Solvent B), was maintained at a constant flow rate (0.5 ml/min). Gradient elution of 4-OHE 2 -1-N7Gua and 4-OHE 2 -1-N3Ade adducts was started with 1% B, held for 1 min, increased to 70% B in 2 min and then to 90% B in 2 min, held for 2 min, and then finally increased to 99% B and held for 3 min and equilibrated at 1% B for 2 min.
Before LC-MS and LC-MS/MS analysis of each in vitro sample, a synthetic reference standard of the respective 4-OHE 2 adduct was injected, followed by injection of a 50/50 mobile phase mixture blank to eliminate carry over. Both 4-OHE 2 -1-N7Gua and 4-OHE 2 -1-N3Ade eluted at~5.7 min and showed [M H] ions at m/z 438 and 422, respectively. The MS/MS detection of the Ade adduct product ions of m/z 136, 229 and 257 was followed by selected reaction monitoring, whereas for the Gua adduct, product ions of m/z 152, 272 and 312 were monitored.
For the adducts and conjugates in the in vitro experiment, capillary reversephase HPLC was coupled with ESI MS. The HPLC instrument was an UltraPlus MicroLC system (Micro Tech, Sunnyvale, CA) supplying a total flow of 4 ml/min to a 20-ml Dyna-Mix Plus mixer. The entire mobile phase, which was a binary gradient that was described previously (38) , was introduced to the mass spectrometer via ESI. ESI, MS and MS/MS were conducted with a Finnigan LCQ ion trap (Finnigan, San Jose, CA). The eluent from the HPLC was sprayed to a heated capillary (200 C) by using a spray voltage of 5.7 kV, a nitrogen-sheath gas flow of 55 ml/min, and an auxiliary gas flow of 10 ml/min.
The LCQ was used in the MS/MS mode, whereby the [M H]
ions of the various analytes were isolated with a mass window of m/z 1.5. The excitation energy was 25% of the maximum (~5 eV), and a large portion of the production spectrum was monitored (from m/z 250±600). The spectra were acquired in the profile mode, and each spectrum was an average of two`microscans', each of which was 1.00 s duration.
Results and discussion

Synthesis and structure elucidation of 4-OHE 2 -1-N3Ade and 4-OHE 1 -1-N3Ade
The adduct 4-OHE 2 -1-N3Ade was synthesized by 1,4-Michael addition of Ade to E 2 -3,4-Q (Figure 2) . Reaction of E 2 -3,4-Q with dA did not generate 4-OHE 2 -1-N3Ade, because the N-3 position of dA was shielded by the deoxyribose.
The NMR spectrum of 4-OHE 2 -1-N3Ade clearly shows both a-and b-isomers due to rotational restriction of the N3Ade. This phenomenon was observed previously in the NMR spectrum of 4-OHE 2 -1-N7Gua (25) . Nuclear Overhauser effect NMR (spectrum not shown) indicated that the b-isomer is the major isomer, and the ratio of a/b is approximately 45:55, as seen previously for the 4-OHE 2 -1-N7Gua adduct (25) . While these isomers can be distinguished by NMR, they cannot be separated, because rotation is partially, but not completely, hindered. This was also found for 4-OHE 2 -1-N7Gua (25) .
Characterization of the structure of the adduct was derived from the singlet chemical shift of the 2-H of the CE moiety at 6.14 and 6. Further confirmation of the structure of the adduct was achieved by tandem mass spectrometry (MS/MS) on both an ion trap and a quadrupole time-of-flight (QTOF) mass spectrometer. We present the product-ion spectra obtained on the QTOF because they are more informative. The parent ion [M H] at m/z 422 gives product ions of m/z 390 (loss of methanol presumably), 296, 282, 270 and 256/257 ( Figure 3A) . These ions are all generated by cleavage of the CE rings, as described for similar steroids by Tomer and Gross (39) , and some of the proposed structures are given in Figure 3 . The fragment ion at m/z 256 (C 12 H 10 O 2 N 5 ) also arises by the cleavage of the C-6±C-7 and C-9±C-10 bonds in the CE B-ring. This fragmentation was proposed previously to be a charge driven process (40) , which is initiated by a charge site at the N-9 position of the purine ring system. The ion at m/z 257 is interesting because it is likely to be a radical ion (C 12 H 11 O 2 N 5 ). Radical ions are usually not fragments of closed-shell species unless they are unusually stable. Therefore, we suggest the fragment is a protonated semiquinone (i.e. a distonic ion). The product-ion spectrum of the 4-OHE 1 -1-N3Ade [M H] also shows the doublet at m/z 256 and 257, which suggests that formation of a semiquinone radical ion is general. Further investigations of this characteristic and interesting radical ion are underway. The ion of m/z 136 is important because it is likely to be protonated Ade, which identifies the adduct as a modified Ade.
With the ion trap instrument, the very low energy collisional activation produces principally product ions by losses of small neutral molecules, and as a result, the spectra are less distinctive. Prominent are ions of m/z 405, 404 and 387 resulting from the losses of NH 3 ). At the high collision energy, ions of m/z 365, 281 and 229 become more important, and they are formed by cross-ring cleavages, as discussed above.
4-OHE 1 -1-N3Ade was synthesized, purified and analyzed in the same way. It is also formed as a-and b-isomers in approximately the same ratio. The product-ion spectrum of 4-OHE 1 -1-N3Ade ([M H] 420; Figure 3B ), taken with the QTOF, shows the ions of 310, 296, 282, 270, 256/257 and 228. As for the product-ion spectrum of 4-OHE 2 -1-N3Ade, these ions are structurally significant because they are formed by cross-ring cleavages of the steroid ring. The m/z values for these ions do not shift for 4-OHE 1 -1-N3Ade and 4-OHE 2 -1-N3Ade, indicating that the ion must contain the nucleobase and the base must be located on the A ring of the steroid.
The product-ion spectrum taken with the ion-trap instrument shows that the preferred product ions are of m/z 403, 402, 391, 386, 385 and 373, which are formed by the losses of small molecules, as was described above for 4-OHE 2 -1-N3Ade. The m/z values of these products shift down by two m/z units with respect to those of the 4-OHE 2 -1-N3Ade, indicating they contain the CE moiety.
In the m/z range below 300, there is a series of fragments at m/z 296, 257, 256, 229, 228 and 201 that were also observed in the product-ion spectrum of 4-OHE 2 -1-N3Ade (discussed above). Fragmentation of 4-OHE 1 -1-N3Ade gives, as expected, a fragment of m/z 136, confirming the presence of the Ade moiety, but the abundance of this ion is considerably lower than that seen with the QTOF.
Formation of 4-OHE 2 -DNA adducts in vitro E 2 -3,4-Q was directly reacted with DNA, as well as 4-OHE 2 activated by horseradish peroxidase, lactoperoxidase, tyrosinase or phenobarbital-induced rat liver microsomes (Table I) . In all of the reactions, the depurinating adducts A B Fig. 3 . MS/MS of (A) 4-OHE 2 -1-N3Ade and (B) 4-OHE 1 -1-N3Ade. The structures of the product ions are speculative and are given to show the utility of the fragmentation.
DNA adducts of E 2 -3,4-Q formed in vitro and in vivo 4-OHE 2 -1-N7Gua and 4-OHE 2 -1-N3Ade constituted 499.9% of the adducts detected, and the level of stable adducts was 50.1 mmol/mol DNA-P. Approximately equal amounts of the two depurinating adducts were observed, except with activation by lactoperoxidase, which resulted in more N7Gua than N3Ade adduct. Tyrosinase yielded the lowest level of adducts, and microsomes gave about half the amounts detected from reaction of the quinone or 4-OHE 2 activated with a peroxidase.
The HPLC detections of the adducts were confirmed by LC/ MS/MS using a triple quadrupole mass spectrometer and selected reaction monitoring. We In the absence of internal standards, we decided not to quantify the amounts of the adducts by mass spectrometry.
These results confirm that oxidation of CE can be obtained by both peroxidases and cytochrome P450, and the oxidized material does react with DNA in vitro and cause depurination.
Estrogen metabolites, conjugates and depurinating adducts in mammary tissue
Female ACI rats were treated by intramammillary injection of 4-OHE 2 or E 2 -3,4-Q for 1 h, and the mammary tissue was excised and analyzed for estrogen metabolites and conjugates or for estrogen±DNA adducts. Hexane was used to extract lipids from the mammary tissue. To extract estrogen metabolites and conjugates, the mammary tissue was suspended in 50 mM ammonium acetate, pH 5.0, with 2 mg/ml ascorbic acid to minimize oxidation of the estrogen derivatives. The extracts were passed through a Bond-Elut Certify II cartridge with non-polar and strong anion exchange properties. Untreated tissue samples spiked with 250 pmol of standard analytes/g tissue were used to determine the percentage of recovery of the various compounds. Recovery of estrogens, CE and their methoxy derivatives was 490%, whereas recovery of thioether conjugates and depurinating DNA adducts was 60±90%.
In the mammary tissue treated with E 2 -3,4-Q, the major metabolic event was reduction to 4-OHE 2 (Table II) . The amount corresponded to~40% of that detected when the mammary tissue was treated with 4-OHE 2 itself (see below). A significant amount of 4-OCH 3 E 2 was detected. In addition, a small amount of E 2 was unexpectedly detected, although E 2 was not detected in the mammary tissue from control rats treated with DMSO.
The amounts of thioether conjugates were substantial, and the major ones were 4-OHE 2 -2-SG and 4-OHE 2 -2-Cys. Small amounts of 4-OHE 2 -2-NAcCys were also obtained. The conversion to estrone derivatives was very limited, and they consisted of 4-OHE 1 and traces of 4-OHE 1 -2-Cys.
When the mammary tissue was treated with 4-OHE 2 , methylation to form 4-OCH 3 E 2 was somewhat greater than oxidation to the corresponding quinone, as evidenced by 4-OHE 2 -2-SG, 4-OHE 2 -2-Cys and a small amount of 4-OHE 2 -2-NAcCys. Unexpectedly, E 2 , as well as 2-OHE 2 and 2-OCH 3 E 2 , were detected following treatment with 4-OHE 2 . We do not know how these metabolites are formed, but we can speculate that induction of aromatase occurred, producing E 2 and, thus, the small amount of 2-OHE 2 metabolites.
We attempted to validate the detections of the conjugates with LC/MS/MS on an ion-trap mass spectrometer interfaced to capillary HPLC. Although the data suggest the presence of these materials, their amounts were too low in all cases to afford convincing product-ion spectra.
To analyze depurinating DNA adducts, mammary tissue was Soxhlet-extracted with chloroform/methanol. The extracts were first fractionated on preparative HPLC, and then the adduct-containing fractions were analyzed by HPLC with a CoulChem electrochemical detector.
In the group of rats treated with E 2 -3,4-Q, both the 4-OHE 2 -1-N7Gua and 4-OHE 2 -1-N3Ade adducts were detected, and in lesser amount the corresponding estrone adducts (Table III) . Approximately equal amounts of N7Gua and N3Ade adducts were detected. The level of stable DNA adducts was 50.1% of the total adducts. When the rats were injected with 4-OHE 2 , the same conversion of E 2 to E 1 was observed as with E 2 -3,4-Q. Slightly more N7Gua adducts (139 mmol/g tissue) were detected than N3Ade adducts (112 mmol/g tissue). The level of stable DNA adducts was 50.1% of the total adducts. The amount of total adducts obtained after treatment with the proximate metabolite 4-OHE 2 was~40% greater than that observed in the rats treated with the ultimate metabolite E 2 -3,4-Q. This is presumably due to the high reactivity of the quinone, which can react indiscriminately with various cellular molecules. In contrast, the 4-OHE 2 can be oxidatively metabolized to E 2 -3,4-Q in regions close to the DNA.
We also conducted validation experiments with LC/MS/MS on the capillary HPLC/ion-trap mass spectrometer for three samples. For one sample, we were able not only to detect [M H] ions of the Ade and Gua adducts for E 1 and E 2 , but also to obtain product-ion spectra that agree with the reference spectra of the Ade adducts (Figure 4) . The product-ion spectra were obtained at sufficient collision energy to produce principally the losses of water, ammonia and water plus ammonia (Figure 4 ) but insufficient energy to give the ions in the mid mass range. The analysis of the two other samples showed successful detections of [M H] ions but gave product-ion spectra that were too weak to make a completely convincing validation. We now know that the QTOF is the preferred instrument for detection of these adducts because, as discussed above and seen in Figure 3 , the spectra are considerably more structurally informative. At the time of analysis, however, we had not acquired the QTOF instrument.
Conclusions
The synthesis of 4-OHE 1 (E 2 )-1-N3Ade from E 1 (E 2 )-3,4-Q and Ade has allowed us to demonstrate that this adduct is also formed by reaction of E 2 -3,4-Q or enzymatically activated 4-OHE 2 with DNA. In general, this adduct is formed in roughly the same amount as 4-OHE 2 -1-N7Gua both in vitro and in rat mammary gland in vivo. Detection of GSH conjugates in rat mammary tissue after treatment with 4-OHE 2 or E 2 -3,4-Q indicates a competition between reaction of DNA adducts of E 2 -3,4-Q formed in vitro and in vivo E 1 (E 2 )-3,4-Q with GSH or DNA. The N3Ade and N7Gua depurinating adducts constitute 499% of the total adducts formed in vitro and in vivo. The N3Ade adducts, which are released from DNA instantaneously, generate mutations by error-prone repair (22, 23) . In contrast, the N7Gua adducts, which depurinate with a half-life of~3 h (41), do not induce mutations, presumably because the slow rate of depurination allows the cell to repair correctly the DNA damage (22) .
